Long-Acting Injectable Formulations Comprising an Isoxazoline Active Agent (EP3261617A1)
Summary
The European Patent Office published European patent application EP3261617A1 for Boehringer Ingelheim Vetmedica GmbH covering long-acting injectable formulations comprising isoxazoline active agents. The application classifies under IPC codes A61K 31/422, A61K 31/42, A61K 9/00, and A01N 43/80. The application designates 36 European contracting states including Germany, France, United Kingdom, Italy, Spain, and other EU member states.
What changed
The EPO published European patent application EP3261617A1 filed by Boehringer Ingelheim Vetmedica GmbH for long-acting injectable formulations containing isoxazoline active agents, with filing date April 8, 2026. The application covers methods of preparing and using these formulations, classified under multiple IPC codes related to pharmaceutical compositions (A61K) and parasiticidal agents (A01N, A61P).
For pharmaceutical manufacturers and animal health companies, this published application establishes a priority date for isoxazoline injectable formulation claims. Competitors developing similar long-acting parasiticidal injectables should conduct freedom-to-operate analyses and monitor the prosecution of this application through the EPO examination process.
What to do next
- Monitor patent register for examination status
- Review application claims for freedom-to-operate analysis
- Assess IP portfolio implications for animal health products
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
LONG-ACTING INJECTABLE FORMULATIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF
Publication EP3261617A1 Kind: A1 Apr 08, 2026
Applicants
Boehringer Ingelheim Vetmedica GmbH
Inventors
CADY, Susan, Mancini, CHEIFETZ, Peter, GALESKA, Izabela, DE FALLOIS, Loic Le Hir
IPC Classifications
A61K 31/422 20060101AFI20251030BHEP A61P 43/00 20060101ALI20251030BHEP A61P 33/14 20060101ALI20251030BHEP A61P 33/00 20060101ALI20251030BHEP A61K 47/10 20170101ALI20251030BHEP A61K 31/42 20060101ALI20251030BHEP A61K 31/69 20060101ALI20251030BHEP A01N 43/80 20060101ALI20251030BHEP A61P 33/10 20060101ALI20251030BHEP A61K 9/00 20060101ALI20251030BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.